injection 1 hour in the dark period of either 0.1% wt/vol BSA (vehicle) or CCK-8 sulfated (2 or 4 g/kg body weight
Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Erondu N, Shaw W, et al
GLP-1 receptor agonists offer unique benefits, including weight loss and cardiovascular protection, which are not provided by all diabetes medications
The relationship between dysregulated insulin metabolism and migraine involves several interconnected pathways: TRPV1 sensitization and CGRP release, mitochondrial dysfunction with oxidative stress, and systemic and neurogenic inflammation
GLP-1 injections mimic a natural hormone that regulates appetite, slows digestion, and helps control blood sugar levels
Prices cannot exceed those published by CMED on the Anvisa Portal